Open AccessInterleukin-1 beta inhibition with canakinumab and reducing lung cancer—subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)
Author(s) -
David C. Crossman,
Alexander Rothman
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.07.50
Subject(s) - canakinumab , medicine , myocardial infarction , lung cancer , disease , anakinra